Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes

Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes

<p>Overall survival of ATM, BRCA2 mutant, and HRDother mPCs.</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Justin Hwang (15925675) (author)
Diğer Yazarlar:	Xiaolei Shi (15925678) (author), Andrew Elliott (15925681) (author), Taylor E. Arnoff (14963396) (author), Julie McGrath (15078600) (author), Joanne Xiu (15051480) (author), Phillip Walker (15925684) (author), Hannah E. Bergom (15925687) (author), Abderrahman Day (15925690) (author), Shihab Ahmed (15925693) (author), Sydney Tape (15925696) (author), Allison Makovec (15925699) (author), Atef Ali (15925702) (author), Rami M. Shaker (15925705) (author), Eamon Toye (15925708) (author), Rachel Passow (15925711) (author), John R. Lozada (15925714) (author), Jinhua Wang (15925717) (author), Emil Lou (14957109) (author), Kent W. Mouw (15925720) (author), Benedito A. Carneiro (15925723) (author), Elisabeth I. Heath (15024674) (author), Rana R. McKay (15062884) (author), W. Michael Korn (15021032) (author), Chadi Nabhan (15051498) (author), Charles J. Ryan (15037635) (author), Emmanuel S. Antonarakis (14971443) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Molecular and Cellular Biology Genome Biology Comparative transcriptomics Functional genomics
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Supplementary Figure 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Yazar:: Justin Hwang (15925675)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Yazar:: Justin Hwang (15925675)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Yazar:: Justin Hwang (15925675)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Yazar:: Justin Hwang (15925675)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
Yazar:: Justin Hwang (15925675)
Baskı/Yayın Bilgisi: (2025)

Structural variants of <i>Fragaria vesca</i>
Yazar:: Minto Odagiri (22680003)
Baskı/Yayın Bilgisi: (2025)

Gene expression data of <i>Fragaria vesca</i>
Yazar:: Minto Odagiri (22680003)
Baskı/Yayın Bilgisi: (2025)

Processed snRNA-seq data from wild-type and <i>Pink1</i>-deficient mouse gut
Yazar:: Muhammad Junaid (14524523)
Baskı/Yayın Bilgisi: (2025)

Supplementary fig 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Yazar:: Jiwei Bai (15051797)
Baskı/Yayın Bilgisi: (2025)

Supplementary fig 2 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Yazar:: Jiwei Bai (15051797)
Baskı/Yayın Bilgisi: (2025)

Supplementary fig 3 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Yazar:: Jiwei Bai (15051797)
Baskı/Yayın Bilgisi: (2025)

Supplementary fig 4 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Yazar:: Jiwei Bai (15051797)
Baskı/Yayın Bilgisi: (2025)

Supplementary fig 5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Yazar:: Jiwei Bai (15051797)
Baskı/Yayın Bilgisi: (2025)

Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Yazar:: Jiwei Bai (15051797)
Baskı/Yayın Bilgisi: (2025)

liverRegression code.
Yazar:: Amy Stephen (22684448)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Clinical Relevance of <i>BRCA1</i> Promoter Methylation Testing in Patients with Ovarian Cancer
Yazar:: Félix Blanc-Durand (15049400)
Baskı/Yayın Bilgisi: (2025)

scRNA-seq, Oligodendrocyte-Lineage Meta-Atlas
Yazar:: Nicholas Mikolajewicz (11242755)
Baskı/Yayın Bilgisi: (2025)

Data file 1. Figure 1. Overview of <i>L. loa</i> specimen and genomic representation
Yazar:: Jeanne Arline Rajaonarivelo (17282572)
Baskı/Yayın Bilgisi: (2025)

<b>Demographic History and </b><b>Natural Selection</b><b> Regimes Shape Divergent Genomic Architectures in Two Endangered Island Oaks</b>
Yazar:: Wenji Luo (4760160)
Baskı/Yayın Bilgisi: (2025)

<i>K. pneumoniae</i> genomes represented in amr.watch as of 31 March 2025, filtered by the presence of the carbapenem resistance gene, <i>bla</i><sub>NDM-5</sub>.
Yazar:: Sophia David (4172902)
Baskı/Yayın Bilgisi: (2025)

<b>Evolution of extensive neo-sex chromosomes and PAR shift in </b><b><i>Agapornis</i></b><b> lovebirds (</b><b>Supporting files, FISH raw data)</b>
Yazar:: Haoran Luo (16515177)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S1 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S10 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S11 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S12 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S2 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S3 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S4 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S5 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S6 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S7 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

Supplementary Spreadsheet S9 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Yazar:: Eileen M. Boyle (15015425)
Baskı/Yayın Bilgisi: (2025)

The interactive amr.watch application here shows an overview from 179,518 <i>E. coli</i> genomes available as of 31 March 2025.
Yazar:: Sophia David (4172902)
Baskı/Yayın Bilgisi: (2025)

Table S1 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
Yazar:: Lenka Stolarova (16547259)
Baskı/Yayın Bilgisi: (2025)

Table S2 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
Yazar:: Lenka Stolarova (16547259)
Baskı/Yayın Bilgisi: (2025)

Table S3 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
Yazar:: Lenka Stolarova (16547259)
Baskı/Yayın Bilgisi: (2025)

DeepEvo
Yazar:: Juntian Qi (22578974)
Baskı/Yayın Bilgisi: (2025)

Table S2 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
Yazar:: Elena Llano (14963220)
Baskı/Yayın Bilgisi: (2025)

Table S3 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
Yazar:: Elena Llano (14963220)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_fefsvvil4jlvuh60riud9f690i